Meta AnalysisID 4006
含动物双歧杆菌乳亚种CNCM I-2494/DN-173010和乳酸菌的发酵乳制品对一般人群胃肠道不适影响的系统评价与Meta分析
CRD42015016660
Is a fermented milk product that includes Bifidobacteria animalis ssp lactis CNCM I-2494/DN-173010 and lactic acid bacteria effective in reducing gastrointestinal discomfort in the general adult population.
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 4006
- Evidence Id
- 12564
- Core Evidence Id
- 12564
- Source Meta Analysis Id
- 3962
- Herb2 Meta Analysis Id
- HBMA003962
- Crd Id
- CRD42015016660
- Title
- Systematic review and meta-analysis of the effects of a fermented milk product that includes Bifidobacteria animalis ssp lactis CNCM I-2494/DN-173010 and lactic acid bacteria on gastrointestinal discomfort in the general population
- Review Question
- Is a fermented milk product that includes Bifidobacteria animalis ssp lactis CNCM I-2494/DN-173010 and lactic acid bacteria effective in reducing gastrointestinal discomfort in the general adult population.
- Study Type Included
- Inclusion criteria: double-blind prospective randomised controlled trials; single blind studies will be summarised in the discussion only; Exclusion criteria: unblinded trials
- Condition Being Studied
- Participant
- Animal
- Human Disease Modelled
- Intervention
- Inclusion criteria: Fermented milk product that includes Bifidobacteria animalis ssp lactis CNCM I-2494/DN-173010 and lactic acid bacteria (any dose) consumed for at least four weeks. Exclusion criteria: A fermented milk product that includes Bifidobacteria animalis ssp lactis CNCM I-2494/DN-173010 and lactic acid bacteria combined with other functional ingredients such as prebiotics or vitamins.
- Comparator Control
- Eligible comparators: A control product which may include other live bacteria, such as yogurt cultures. A control product can be: • non-fermented dairy products without probiotics with same taste, colour appearance (to allow double-blinding); • the heat-treated active product (i.e. the bacteria are not alive in the control product and the probiotics (living Bifidobacteria bacteria) are compared to dead bacteria in the same dairy matrix); • another fermented milk product without “active” probiotics (e.g. a standard yoghurt without the Bifidobacteria). Ineligible criteria: • a fermented milk product that includes Bifidobacteria animalis ssp lactis CNCM I-2494/DN-173010 and lactic acid bacteria combined with additional ingredients, such as prebiotics, which are different to additional ingredients included in the intervention. • Standard yoghurts containing Bifidobacteria; • Other prebiotics.
- Main Outcome
- Outcome Measure
- Additional Outcome
- Study Method
- Keyword
- Bifidobacterium; Cultured Milk Products; Gastrointestinal Diseases; Humans; Lactic Acid; Probiotics
- Contact
- Organisational Affiliation
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- England
- Review Stage
- First Submission Date
- Registration Date
- 2015-02-10
- Anticipated Start Date
- Anticipated Completion Date
- Title Cn
- 含动物双歧杆菌乳亚种CNCM I-2494/DN-173010和乳酸菌的发酵乳制品对一般人群胃肠道不适影响的系统评价与Meta分析
- Title En
- Systematic review and meta-analysis of the effects of a fermented milk product that includes Bifidobacteria animalis ssp lactis CNCM I-2494/DN-173010 and lactic acid bacteria on gastrointestinal discomfort in the general population
- Bilingual Status
- complete